HYPERTENSION AND THE KIDNEY

REFERENCES

• Perera GA. Hypertensive vascu Ear disease: description and natu-raL history.JChronDis 1955; 1:33–42.
   PubMedGoogle Scholar
• BuckaLew V, Berg R, Wang S-R et al PrevaLence of hypertension in 1,795 subjects with chronic renaE disease: The modification of diet in renaE disease study baseline cohort. Am J Kidney Dis 1996; 28: 811–21.
   PubMed Web of Science ®Google Scholar
• Siewert-DeRe, Ljungman S, Andersson O and WiLheLmsen L. Does treated primary hypertension Lead to end-stage renaE disease? A 20-year foRow-up of the primary prevention study by Gote-borg, [Sweden]. Nephrol Dial Transplant 1998; 13: 3084–90.
   Web of Science ®Google Scholar
• Freis E, Arias L, Armstrong M. et al Effects of treatment on mor-bidity in hypertension. JAMA 1967; 202: 1028–34.
   Google Scholar
• Veterans Administration Cooperative Study Group on Antihy-pertensive Agents. Effects of treatment on morbidity in hyper-tension. II. Results in patients with diastolic blood pressure av-eraging 90 through 114 mmHg. JAMA 1970; 213: 1143–52.
   Web of Science ®Google Scholar
• Klag M, Whelton P, Randall B. et al. Blood pressure and end-stagerenal disease in men. N Engl J Med 1996; 334: 13–8.
   PubMed Web of Science ®Google Scholar
• Klag M, Whelton P, Randall B. et al. End-stage renal disease in african-american and white men. 16-year MRFIT findings. JAMA 1997; 277: 1293–6.
   PubMed Web of Science ®Google Scholar
• Hsu C-Y, McCulloch C, Darbinian J, Go A, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005; 165: 923–8.
   PubMed Web of Science ®Google Scholar
• National Kidney Fundation. K/DOQIClinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis 2004; 43 (suppl 1): 592–5100.
   Google Scholar
• Andersen M, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis 2005; 45: 994–1001.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Munemura M, Usami T. et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int 2004; 65:621–5.
   PubMed Web of Science ®Google Scholar
• Hermida R, Ayala D, Calvo C. et al. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension 2005; 46 (part 2): 1053–9.
   Web of Science ®Google Scholar
• Guyton A, Coleman T, Cowley A et a LArterial pressure regulation: overriding dominance of the kidneys in long-term regulation in hypertension. Am J Med 1972; 52: 584–94.
   PubMed Web of Science ®Google Scholar
• Rettig R and Grisk O. The kidney as a determinant of genetic hypertension. Evidence from renal transplantation studies. Hypertension 2005; 46: 463–8.
   Web of Science ®Google Scholar
• Curtis J, Luke R, Dustan H. et al. Remission of essential hyperten-sion after renal transplantation. N Engl J Med 1983; 309: 1009–15.
   PubMed Web of Science ®Google Scholar
• Krzesinski J-M, Warking X, Goffard A et Rorive G.Anomalie rénale de ['excretion sodée, un marqueur de la predisposition hérédi-taire a ['hypertension artérielle. Arch Mal Cceur 1989; 82: 1245–8.
   Google Scholar
• Krzesinski J-M, Saint-Remy A, Du F and Rorive G. Red blood cell Na-Li countertransport, hypertensive heredity, and cardiovas-cular risk in young adults. Am J Hypertens 1993; 6:314–6.
   Web of Science ®Google Scholar
• Brenner B, Garcia D, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988;1: 335–47.
   PubMed Web of Science ®Google Scholar
• Keller G, Zimmer G, Mall G, Ritz E and Amann K. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348:101–8.
   PubMed Web of Science ®Google Scholar
• Freedman B, Iskandar S and Appel R. The [ink between hyperten-sion and nephrosclerosis. Am J Kidney Dis 1995; 25:207–21.
   PubMed Web of Science ®Google Scholar
• Zucchelli P and Zuccala A. Primary hypertension - How does it cause renal failure? Nephrol Dial Transplant 1994; 9:223–5.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Kang D-H, Feig D et al. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int 2006; 69: 1722–5.
   PubMed Web of Science ®Google Scholar
• Hill GS, Heudes D, Jacquot C, Gauthier E and Bariéty J. Morpho-metric evidence for impairment of renal autoregulation in ad-vanced essential hypertension. Kidney Int 2006; 69:823–31.
   PubMed Web of Science ®Google Scholar
• Ruilope L, Campo C and Rodicio J. Relationship between blood pressure and renal function.' Hypertens 1994,12 (suppl 8): S55–59.
   Google Scholar
• Campese VM, Mitra N and Sandee D. Hypertension in renal parenchymal disease:Why is it so resistant to treatment? Kidney Int 2006; 69: 967–73.
   Google Scholar
• Brown M and Whitworth J. Hypertension in human renal disease. J Hypertens 1992; 10: 701–2.
   PubMed Web of Science ®Google Scholar
• Cianciaruso B, Bellizzi V, Minutolo R. et al. Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol 1996; 7: 306–13.
   Web of Science ®Google Scholar
• Krzesinski J-M, Rorive G. Influence of sodium balance on ure-mic red blood cell ion transport. Nephron 1988; 49: 126–31.
   PubMedGoogle Scholar
• Bakris G, Williams M, Dworkin L. et al. Preserving renal function in adults with hypertension and diabetes:A consensus approach. Am J Kidney Dis 2000; 36:646–61.
   PubMed Web of Science ®Google Scholar
• Brazy P and Fitzwilliam F. Progressive renal disease: Role of race and antihypertensive medications. Kidney Int 1990; 37: 1113–9.
   PubMed Web of Science ®Google Scholar
• Oldrizzi L, Bright C, De Biase V, Maschio G. The place of hyper-tension among the risk factors for renal function in chronic renal failure. Am J Kidney Dis 1993; 21 (suppl 2): 119–23.
   Google Scholar
• Peterson J, Adler S, Burkart M et al. Blood pressure control, pro-teinuria, and the progression of renal disease.Ann Int Med 1995; 123: 754–62.
   PubMed Web of Science ®Google Scholar
• Ruggenenti P, Perna A and Remuzzi G., on behalf of the investi-gators of the GISEN Group. Retarding progression of chronic renal disease:The neglected issue of residual proteinuria. Kidney Int 2003; 63:2254–61.
   PubMed Web of Science ®Google Scholar
• Shulman N, Ford C, Hall D et al. Prognostic value of serum cre-atinine and effect of treatment of hypertension on renal func-tion. Hypertension 1989; 13 (suppl 1):I-80-1–93.
   Google Scholar
• de Leeuw P, Ruilope L, Palmer C et al. Clinical significance of renal function in hypertensive patients at high risk. Arch Intern Med 2004; 164: 2459–64.
   PubMed Web of Science ®Google Scholar
• The ALLHAT officers and coordinators for the ALLHAT collabora-tive research group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibi-tor or calcium channel Mocker vs diuretic.The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981–97.
   Web of Science ®Google Scholar
• Dalhöf B, Sever P, Poulter N. et al., for the ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895–906.
   PubMed Web of Science ®Google Scholar
• Wright J, Ba kris G, Greene T. et al. Effect of blood pressure low-ering and antihypertensive drug class on progression of hyper-tensive kidney disease: results from the AASK trial. JAMA 2002; 288: 2421–31.
   PubMed Web of Science ®Google Scholar
• Agodoa L, Appel L, Ba kris G. et al. Effect of ramiprilvs amlodipine on renal outcomes in hypertensive nephrosclerosis. A rand-omized controlled trial. JAMA 2001; 285: 2719–28.
   PubMed Web of Science ®Google Scholar
• Sarnak M, Greene T, Wang X. et al. The effect of a lower target blood pressure on the progression of kidney disease: Long-term follow-up of the modification of diet in renal disease study. Ann Intern Med 2005; 142: 342–51.
   PubMed Web of Science ®Google Scholar
• Ruggenenti P, Perna A, Ganeva L. et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): mu lticentre, randomised controlled trial. Lan-cet 2005; 365: 939–46.
   PubMed Web of Science ®Google Scholar
• Ruggenenti P, Perna A, Gherardi G. et al. Renoprotective proper-ties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999; 354: 359–64.
   PubMed Web of Science ®Google Scholar
• Maschio G, Alberti D, Janin G. et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939–45.
   PubMed Web of Science ®Google Scholar
• Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin-II receptor Mocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 2003; 361: 114–24.
   Google Scholar
• Zucchelli P, Zuccala A, Borghi M. et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992; 42: 452–8.
   PubMed Web of Science ®Google Scholar
• Jafar T, Stark P, Schmid H. et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition. Ann Intern Med 2003; 139: 244–52.
   PubMed Web of Science ®Google Scholar
• Sanders P. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 2004; 43: 142–6.
   Web of Science ®Google Scholar
• Orth S, Ogata H and Ritz E. Smoking and the kidney. Nephrol Dial Transplant 2000; 15: 1509–11.
   PubMed Web of Science ®Google Scholar
• Baggio B, Budakovic A, Perissinotto E. et al. Atherosclerosis risk factors and renal function in the elderly: the role of hyperfi-brinogenaemia and smoking. Results from the Italian Longitu-dinal Study on Ageing (ILSA). Nephrol Dial Transplant 2005; 20: 114–23.
   Web of Science ®Google Scholar
• Peralta C, Hicks L, Chertow G. et al. Control of hypertension in adults with chronic kidney disease in the United States. Hyper-tension 2005; 45: 1119–24.
   Web of Science ®Google Scholar
• The Guidelines Committee. 2003 European Society of Hyperten-sion - European Society of Cardiology guidelines for the man-agement of arterial hypertension. J Hypertens 2003; 21: 1011–58.
   Google Scholar
• Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insuffi-ciency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Int Med 2001, 134: 629–36.
   PubMed Web of Science ®Google Scholar
• National Kidney Fundation. K/DOQIClinical Practice Guidelines on Hypertension and AntihypertensiveAgents in Chronic Kidney Disease. Am J Kidney Dis 2004; 43 (suppl 1): S16–541.
   Google Scholar
• Verma S and Strauss M Angiotensin receptor Mockers and myo-cardial infarction. British Medical/ 2004; 329:1248–9.
   PubMed Web of Science ®Google Scholar
• Derwa A, Peeters P, Vanholder R. Calcium channel Mockers in the prevention of end stage renal disease: a review. Acta Clinica Belgica 2004; 59: 44–56.
   PubMed Web of Science ®Google Scholar
• Gashti C and Bakris G. The role of calcium antagonists in chronic kidney disease. Curr Opinion Nephrol Hypertens 2004; 13: 155–61.
   Web of Science ®Google Scholar
• Bakris G, Weir M, Secic M, Campbell B and McNulty W. Differ-ential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int 2004;65:1991–2002.
   PubMed Web of Science ®Google Scholar
• MacKinnon M, Shurraw S, Akbari A. et al. Combination therapy with an angiotensin receptor Mocker and an ACE inhibitor in proteinuric renal disease: A systematic review of the efficacy and safety data. Am J Kidney Dis 2006; 48: 8–20.
   PubMed Web of Science ®Google Scholar
• Aperloo A, de Zeeuw D and De Jong P. A short-term antihyper-tensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 1997; 51: 793–7.
   Web of Science ®Google Scholar